Is curing patients a sustainable business model?” Goldman Sachs analysts ask

Analyst report notes that Gilead’s hep C cure will make less than $4 billion this year.





The Goldman Sachs bank logo is seen reflected on the screen of a mobile phone in this photo illustration on November 15, 2017.
Enlarge / The Goldman Sachs bank logo is seen reflected on the screen of a mobile phone in this photo illustration on November 15, 2017.


532 with 258 posters participating, including story author

One-shot cures for diseases are not great for business—more specifically, they’re bad for longterm profits—Goldman Sachs analysts noted in an April 10 report for biotech clients, first reported by CNBC.

The investment banks’ report, titled “The Genome Revolution,” asks clients the touchy question: “Is curing patients a sustainable business model?” The answer may be “no,” according to follow-up information provided.


Analyst Salveen Richter and colleagues laid it out:

The potential to deliver “one shot cures” is one of the most attractive aspects of gene therapy, genetically engineered cell therapy, and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies... While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.

For a real-world example, they pointed to Gilead Sciences, which markets treatments for hepatitis C that have cure rates exceeding 90 percent. In 2015, the company’s hepatitis C treatment sales peaked at $12.5 billion. But as more people were cured and there were fewer infected individuals to spread the disease, sales began to languish. Goldman Sachs analysts estimate that the treatments will bring in less than $4 billion this year.

“[Gilead]’s rapid rise and fall of its hepatitis C franchise highlights one of the dynamics of an effective drug that permanently cures a disease, resulting in a gradual exhaustion of the prevalent pool of patients,” the analysts wrote. The report noted that diseases such as common cancers—where the “incident pool remains stable”—are less risky for business.

To get around the sustainability issue overall, the report suggests that biotech companies focus on diseases or conditions that seem to be becoming more common and/or are already high-incidence. It also suggests that companies be innovative and constantly expanding their portfolio of treatments. This can “offset the declining revenue trajectory of prior assets." Lastly, it hints that, as such cures come to fruition, they could open up more investment opportunities in treatments for “disease of aging.”

Ars reached out to Goldman Sachs, which confirmed the content of the report but declined to comment.

This post has been updated.


Views: 36

Comment

You need to be a member of 12160 Social Network to add comments!

Join 12160 Social Network

Comment by Chris of the family Masters on May 16, 2019 at 7:54pm

This sums it up. Rockefeller's 'medicine' is a fraud.

Comment by Diana on May 16, 2019 at 7:44pm

They actually had to do a report?  It seems pretty obvious that the big money is in drugs that patients have to take for life - steady income stream.  It's even better if other drugs have to be prescribed for side effects from the original drug.

Latest Activity

oldranger_68 favorited rlionhearted_3's photo
1 hour ago
Chris of the family Masters posted videos
2 hours ago
Old Denmark commented on James T. Kirk's video
Thumbnail

Any firearms in the vehicle today?

"Finally a few people have started to advocate for gun rights in Scandinavia again. Since they were…"
4 hours ago
Old Denmark favorited James T. Kirk's video
4 hours ago
Old Denmark posted a status
"WATCH LIVE: Tornado watch issued for western Oklahoma. http://www.youtube.com/watch?v=t75MUU3m7oM"
4 hours ago
James Roberts favorited Diana's photo
4 hours ago
James Roberts commented on Diana's photo
4 hours ago
James Roberts favorited Diana's photo
4 hours ago
James Roberts posted a photo
5 hours ago
Diana favorited Chris of the family Masters's video
6 hours ago
Diana favorited rlionhearted_3's photo
6 hours ago
Diana favorited Chris of the family Masters's blog post ORDERING A PIZZA FROM GOOGLE
7 hours ago
Chris of the family Masters favorited Old Denmark's video
7 hours ago
Chris of the family Masters favorited Anti Everything's blog post Medical Industrial Corporations Will Kill You
7 hours ago
Central Scrutinizer commented on Diana's photo
Thumbnail

Who Must Go?

""There's no crying in politics""
8 hours ago
Central Scrutinizer favorited Diana's photo
8 hours ago

Please remember this website is supported by your donations...

© 2019   Created by truth.   Powered by

Badges  |  Report an Issue  |  Terms of Service

content and site copyright 12160.info 2007-2015 - all rights reserved. unless otherwise noted